One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-123747
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 5 |
Affiliation: Columbia University Irving Medical Center, Churchill Hospital, University of Oxford, University of Birmingham, University College London, University of California, San Francisco, Georgetown University, Memorial Sloan Kettering Cancer Center, University of Virginia, Fred Hutch Cancer Center, University of California, San Diego, Northwell Health, University of Rochester, Levine Cancer Institute, University of South Carolina, Moffitt Cancer Center, Swedish Medical Center, Duke Medical Center, Hospital Israelita Albert Einstein, Roswell Park Cancer Institute, St James's University Hospital, The London College, University of Pennsylvania, Cornell University, University of North Carolina at Chapel Hill, Cleveland Clinic, SUNY Upstate Medical University, North Shore University Hospital, Seattle Cancer Care Alliance, Cancer Research Center, University of Pittsburgh Medical Center, University at Buffalo, State University of New York, Nottingham University Hospitals NHS Trust, Novant Health, University of Rochester Medical Center
Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
